Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

: Radue E W, Stuart W H, Calabresi P A, Confavreux C, Galetta S L, Rudick R A, Lublin F D, Weinstock-Guttman B, Wynn D R, Fisher E, Papadopoulou A, Lynn F, Panzara M A, Sandrock A W, SENTINEL Investigators 2010 (Incl. Soilu-Hänninen M )

: 2010

: Journal of the Neurological Sciences

: 1-2

: 292

: 1-2

: 28

: 35

: 8

: 0022-510X

DOI: https://doi.org/10.1016/j.jns.2010.02.012